12 Months of Long Covid Recovery: A Composite Case Study

A Note on This Article

This is a composite case, not a single real patient. The walkthrough below is drawn from the patient patterns we consistently see in severe Long Covid recovery on the Scorch Protocol. The specific timeline, symptom progression, and milestones reflect the typical course for a moderately-to-severely affected patient in the post-2020 cohort. The composite framing is explicit because fabricating individual patient testimonials would be both an E-E-A-T violation and inconsistent with the editorial standards of this site. The patterns are real. The specific person is an archetype.

For the readers seeking "is this the path that fits my situation," composite cases serve a different purpose than individual testimonials. They show you what the typical course looks like at each stage so you can calibrate your expectations and recognize where you are in the arc.

The Archetype

Female, 38 years old, professional, two children. Hit Covid in late 2021. Mild acute illness (no hospitalization). Returned to work after two weeks. Within three months, the chronic phase had emerged: profound fatigue that sleep did not touch, brain fog that made her job increasingly difficult, new food sensitivities, episodes of tachycardia and dizziness when standing, sleep that was simultaneously exhausting and unrefreshing.

Pre-illness stressor profile: 5 years of intermittent fasting (16:8), recreational marathon training, two cups of coffee per day, slow-metabolizer CYP1A2 genotype (later discovered), chronic 5-6 hours of sleep through her younger child's first year. The reserves were thin going into the viral hit.

By the time she found the Scorch Protocol, she had been ill for approximately 2.5 years and had been through:

• Two Long Covid clinic referrals
• LDN (modest improvement, plateaued)
• A methylene blue protocol (no sustained benefit)
• Mitochondrial supplement stack (CoQ10, PQQ, NAD+)
• A round of Paxlovid (initial improvement, rebound back to baseline within 6 weeks)
• Cromolyn sodium for emerging MCAS
• Compression garments and salt loading for emerging POTS

Her labs at protocol entry: TSH 2.1 (normal range), free T4 1.1 (normal range), free T3 2.8 (lower end of normal range), morning cortisol 12 (low-normal). Basal body temperature averaging 96.8°F. Resting heart rate 78. Standing heart rate increase 45 bpm. Functional capacity approximately 30% of pre-illness baseline.

Month 0: Pre-Protocol Stabilization

The first month of the protocol is preparation, not intervention. The patient was already on cromolyn sodium and antihistamines for MCAS; these were maintained. Salt loading and compression garments for POTS continued. The dietary preparation began: clean nutrient-dense whole foods, partial keto adaptation to make the upcoming metabolic transitions easier, 1 gram of carnitine daily to accelerate fat utilization efficiency. Baseline labs ordered. Initial 24-hour water fast completed comfortably.

End of month 0: baseline established. Patient is symptomatic but stable. Ready to begin the protocol.

Month 1: First Short Fast Sequence

48-hour water fast in week 1, completed with mild Herxheimer reaction in days 4-5 post-fast (temporary worsening of fatigue and brain fog). 72-hour water fast in week 3 produced more noticeable improvement: clearer thinking for the week post-fast, baseline body temperature climbed to 97.1°F. T3 therapy initiation discussion with prescriber; first SR-T3 prescription obtained.

End of month 1: tolerance for short fasts established. T3 ready to begin. The first 5-day dry fast scheduled for month 2.

Month 2: First 5-Day Dry Fast and T3 Initiation

The first 5-day dry fast at home with buddy system. Pre-fast colon cleanse and liver flush completed in days prior. Fast went largely as expected: day 1 mild thirst, day 2 noticeable thirst with stable energy, day 3 the energy-switching transition (difficult but manageable, the cortisol surge was present and provided the expected energy edge), day 4 stable difficulty with substantially clearer mental state, day 5 the deeper therapeutic window with peak mental clarity.

Refeeding initiated carefully: 300 mL room-temperature water over the first hour, then electrolytes, then easily digestible food (broth, mashed fruit) over the next 12 hours. Daily caloric intake at refeed start: approximately 1,400 kcal.

T3 begun in week 3 of month 2 at 12.5 mcg SR-T3 twice daily. Climbed by 12.5 mcg every 4 days over the following weeks.

End of month 2: substantial subjective improvement. Brain fog noticeably reduced. Resting heart rate 72 (down from 78). Basal body temperature 97.4°F (up from 96.8°F at protocol entry). MCAS reactivity reducing; able to reintroduce one previously trigger food without flare.

Month 3: T3 Cycle Mid-Phase

T3 dose climbing through the gradual climb phase. By mid-month, at 75 mcg SR-T3 daily, basal body temperature climbing to 97.9°F average. Energy substantially improved. Brain fog continues to clear. Caloric tolerance opening: patient now consuming 1,800-2,000 kcal/day without MCAS flares or weight gain.

Mid-month POTS reassessment: standing heart rate increase reduced from 45 bpm to 28 bpm. Cromolyn sodium dose reduced to half (was 200 mg four times daily, now 100 mg four times daily). Compression garments wearing less often.

End of month 3: T3 dose at 100 mcg/day, basal body temperature averaging 98.1°F. Patient describes feeling "human again" for the first time in over two years.

Month 4: T3 Peak Hold and First hGH Cycle Discussion

T3 dose reached 125 mcg/day, basal body temperature stabilized at 98.5°F average. Holding the dose through the peak phase. Substantial energy improvement consolidating. Cognitive symptoms substantially resolved; able to read and engage with complex work content sustainably. POTS symptoms minimal; standing heart rate increase 18 bpm (below POTS threshold). Cromolyn sodium tapered further to 100 mg twice daily.

Discussion with prescriber about hGH therapy for the rebuild phase. Baseline IGF-1 measured: 142 ng/mL (low end of normal range for age). Pre-hGH cardiovascular evaluation cleared. First hGH prescription obtained; planned to begin in month 5 after T3 taper begins.

End of month 4: caloric intake 2,400 kcal/day with steady weight (no significant gain or loss). Pre-illness function level approximately 65% restored.

Month 5: T3 Taper, First hGH Begin

T3 taper begun: 12.5 mcg reduction every 4 days. Desiccated thyroid bridge initiated at half-grain (30 mg) daily during the taper to smooth the HPT recovery. Taper completed over weeks 2-3.

hGH initiated at 1 IU subcutaneous in the evening. Tolerated well; no significant side effects. Energy continuing to improve. Body composition shift noticeable: lean mass return, fat mass stable.

Caloric intake climbing to 2,700 kcal/day with continued steady body composition.

End of month 5: completed first full T3 cycle. hGH cycle in progress. Body temperature stable at 98.4°F on desiccated thyroid alone. Functional capacity approximately 75% of pre-illness baseline.

Month 6: Continued Refeed and hGH

hGH dose increased to 2 IU. Refeed continuing at 70-100 cal/week ascent rate. Caloric intake at 3,000 kcal/day by end of month. Patient returned to recreational running (slowly, half-distance from pre-illness, completed without post-exertional malaise).

Biome rebuild work begun: introduced raw kefir, raw kombucha, and raw unpasteurized kimchi (the trinity) as daily dietary components. Within 4 weeks, noticeable digestive improvement.

End of month 6: body temperature stable at 98.6°F. MCAS reactivity minimal; cromolyn sodium tapered off completely. POTS symptoms absent. Functional capacity approximately 80% of pre-illness baseline.

Month 7: Off-Cycle hGH, Stable Function

hGH off-cycle begun (3-month rest before second cycle). Patient continues on desiccated thyroid maintenance and on T3 as needed. Caloric intake stable at 3,200 kcal/day. Body composition continues to improve: muscle mass approaching pre-illness baseline, body fat percentage at healthy range.

Return to work at full capacity. Cognitive function indistinguishable from pre-illness in subjective assessment.

End of month 7: substantial functional recovery. Patient describes "back to myself" qualitatively.

Months 8-9: Maintenance and Second Dry Fast Cycle

Patient resumed protocol cycle: second 5-day dry fast in month 8. Notably easier than the first; no Herxheimer reaction, mild fatigue post-fast resolving within 3 days. Refeed straightforward. T3 cycle initiated again at lower starting dose (25 mcg/day) and lower peak (75 mcg/day); body temperature held at 98.6°F average through the cycle.

End of month 9: deep cleanup completed, energy floor sustainably elevated.

Months 10-12: Consolidation and Second hGH Cycle

Second hGH cycle begun at 1.5 IU/day for 3 months. Body composition continues to improve. Strength and endurance climbing toward pre-illness levels. Cognitive function fully restored.

By month 12, the patient's metrics:

• Basal body temperature: 98.6°F average (entry baseline: 96.8°F)
• Resting heart rate: 62 (entry baseline: 78)
• Standing heart rate increase: 12 bpm (entry baseline: 45 bpm)
• Functional capacity: 95% of pre-illness baseline
• MCAS medication: none (entry: cromolyn 200 mg QID, multiple antihistamines)
• POTS medication: none (entry: compression garments, daily salt loading)
• Free T3: 4.1 ng/dL (entry: 2.8); in optimal range
• Cortisol AM: 18 (entry: 12); normal range
• IGF-1: 218 ng/mL (entry: 142); mid-normal range

The Composite Reality

This is a typical course for the composite patient described. Real patients vary substantially:

• Some respond faster, particularly patients with shorter illness duration or fewer overlapping conditions (MCAS, POTS) at protocol entry
• Some take longer, particularly long-duration cases (5+ years), patients with severe initial symptoms, or patients with significant co-infection burden requiring antimicrobial layering
• The specific medications and dosing differ; the T3 dose range (60-150 mcg) is what most patients require, but outliers exist
• The hGH cycle timing and dose differ; some patients require longer hGH cycles, some require shorter

The arc is consistent: cleanup → energy restoration → rebuild, in that order, taking 9-18 months for substantial recovery in the moderately-severe Long Covid cohort, longer for severe and long-duration cases.

What this composite is not:

• Not a single real patient (fabricating individual testimonials would damage the editorial integrity of this site)
• Not a guarantee of outcome (individual patient response varies; the protocol is not a guaranteed cure)
• Not a replacement for working with appropriate prescribing physicians for T3, hGH, and other medications described
• Not a substitute for reading the full clinical context in the Long Covid Recovery guide, the dry fasting complete guide, and the protocol pages

What Recognizing Yourself in This Walkthrough Means

If the patient's pre-illness stressor profile sounds like yours, if her presentation at protocol entry matches yours, if the timeline of standard treatments she had been through resembles yours, then the protocol arc described here is the arc you would expect to follow. Variations of months, of specific symptoms, of medication doses, are all expected. The overall pattern (cleanup → energy → rebuild over 9-18 months) is robust.

If she sounds nothing like you, this case probably is not the right calibration point for your recovery, and a different composite case might be more applicable. The composite walkthrough for the 5-year ME/CFS patient with MCAS covers a different archetype.

Where to Start

The protocol entry point is consistent regardless of which composite case fits your situation: appropriate preparation, then the first dry fasting cycle, then T3 initiation. Read the Long Covid Recovery guide for the full mechanism context, then the preparation page, then the dry fasting page for the practical execution.